Clinical trials
Phase 2 Burkitt Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Completed | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 6 |
| Zhejiang University | 2 |
| Beijing Tongren Hospital | 1 |
| Beijing Yongtai Ruike Biotechnology Company Ltd | 1 |
| Chen Suning | 1 |
| Cothera Bioscience, Inc | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 15 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphatic Diseases | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Neoplasm, Residual | 1 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.